Médecine

Paramédical

Autres domaines


S'abonner

Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials - 20/06/20

Doi : 10.1016/j.jogoh.2020.101798 
Ahmed Samy a, Ayman Taher a, Sileem A. Sileem b, Ahmed Mohamed Abdelhakim c, , Mohamed Fathi c, Hisham Haggag a, d, Khaled Ashour e, Shady Abdelsattar Ahmed f, Mohammad Abrar Shareef g, Abdulhadi A. AlAmodi h, Nawal Hamdy Ahmed Keshta i, Hanan Barakat Abu Elyazid Shatat i, Doaa M. Salah i, Ahmed Said Ali j, Eman Abdel Monem El Kattan a, Moutaz Elsherbini a
a Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt 
b Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt 
c Kasr Al-Ainy, Faculty of Medicine, Cairo University, Cairo, Egypt 
d Department of Obstetrics and Gynecology, University of Würzburg, Würzburg, Germany 
e Faculty of Pharmacy, Cairo University, Cairo, Egypt 
f President of Arab Society of Fetal Medicine, Cairo, Egypt 
g Department of Internal Medicine, Sebasticook Valley Hospital, USA 
h School of Public Health, College of Health Sciences Department of Epidemiology and Biostatistics, Jackson State University, Jackson, MS, USA 
i Department of Obstetrics and Gynecology, Faculty of Medicine, Al Azhar University, Girls Branch, Cairo, Egypt 
j Faculty of Medicine, Al-Azhar University, Cairo, Egypt 

Corresponding author at: Faculty of Medicine, Cairo University, 395 Portsaid Street, Bab el-Kalq, Cairo, 11638, Egypt.Faculty of MedicineCairo University395 Portsaid StreetBab el-KalqCairo11638Egypt
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Saturday 20 June 2020

Abstract

Our objective was to assess and rank different pharmacological interventions for relieving endometriosis-related pain. We conducted an online bibliographic search in different databases from their inception until March 2019. We included randomized controlled trials (RCTs) that assessed different medical therapies in the management of endometriosis-related pain. We applied this network meta-analysis (NMA) based on the frequentist approach using statistical package “netmeta” (version 1.0−1) in R software. Our main outcomes were the change in severity of pelvic pain, dysmenorrhea score, non-menstrual pelvic pain score, and dyspareunia score. Overall, 36 RCTs were included in this study (patients no. = 7942). Dienogest (0.94), combined hormonal contraceptives (CHCs) (0.782), and elagolix (0.38) were the highest-ranked interventions for reducing the severity of pelvic pain at three months, while at six months, gonadotropin-releasing hormone (GnRH) analogues (0.75), levonorgestrel-releasing intrauterine system (LNG-IUS) (0.73), and dienogest (0.65) were linked to more reduction in pelvic pain. The ranking p-score showed that GnRH analogues was the highest-ranked treatment for reducing dysmenorrhea at 3 months (1.00), while CHCs were the highest-ranked treatment at 6 months (0.97), followed by GnRH analogues (0.89). GnRH analogues (0.63) and elagolix (0.54) at three months while desogestrel (0.94) and CHCs (0.91) at six months were the highest-ranked treatment to reduce non-menstrual pelvic pain. GnRH analogues and elagolix were the highest-ranked pharmacologic therapies for reducing dyspareunia. In conclusion, CHCs, GnRH analogues, progesterone, and elagolix were the best approaches in reducing the pain of endometriosis.

Le texte complet de cet article est disponible en PDF.

Keywords : Endometriosis, Pain, Pharmacological interventions


Plan


© 2020  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement ou un achat à l’unité.

Déjà abonné à cette revue ?

;

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.